D I A Mir1, A Gupta1, A Dunning2, L Puchi1, C L Robinson1, H-A B Epstein3, P C Sanelli4. 1. From the Departments of Radiology (D.I.A.M., A.G., L.P., C.L.R., P.C.S.). 2. Public Health (A.D., P.C.S.). 3. the Samuel J. Wood Library and C.V. Starr Biomedical Information Center (H.-A.B.E.), Weill Cornell Medical College, New York, NY. 4. From the Departments of Radiology (D.I.A.M., A.G., L.P., C.L.R., P.C.S.)Public Health (A.D., P.C.S.) pcs9001@med.cornell.edu.
Abstract
BACKGROUND AND PURPOSE: Delayed cerebral ischemia is a significant cause of morbidity and mortality after aneurysmal SAH, leading to poor outcomes. The purpose of this study was to evaluate the usefulness of CTP in determining delayed cerebral ischemia in patients with aneurysmal SAH. MATERIALS AND METHODS: We conducted a systematic review evaluating studies that assessed CTP in patients with aneurysmal SAH for determining delayed cerebral ischemia. Studies using any of the following definitions of delayed cerebral ischemia were included in the systematic review: 1) new onset of clinical deterioration, 2) cerebral infarction identified on follow-up CT or MR imaging, and 3) functional disability. A random-effects meta-analysis was performed assessing the strength of association between a positive CTP result and delayed cerebral ischemia. RESULTS: The systematic review identified 218 studies that met our screening criteria, of which 6 cohort studies met the inclusion criteria. These studies encompassed a total of 345 patients, with 155 (45%) of 345 patients classified as having delayed cerebral ischemia and 190 (55%) of 345 patients as not having delayed cerebral ischemia. Admission disease severity was comparable across all groups. Four cohort studies reported CTP test characteristics amenable to the meta-analysis. The weighted averages and ranges of the pooled sensitivity and specificity of CTP in the determination of delayed cerebral ischemia were 0.84 (0.7-0.95) and 0.77 (0.66-0.82), respectively. The pooled odds ratio of 23.14 (95% CI, 5.87-91.19) indicates that patients with aneurysmal SAH with positive CTP test results were approximately 23 times more likely to experience delayed cerebral ischemia compared with patients with negative CTP test results. CONCLUSIONS: Perfusion deficits on CTP are a significant finding in determining delayed cerebral ischemia in aneurysmal SAH. This may be helpful in identifying patients with delayed cerebral ischemia before development of infarction and neurologic deficits.
BACKGROUND AND PURPOSE:Delayed cerebral ischemia is a significant cause of morbidity and mortality after aneurysmalSAH, leading to poor outcomes. The purpose of this study was to evaluate the usefulness of CTP in determining delayed cerebral ischemia in patients with aneurysmalSAH. MATERIALS AND METHODS: We conducted a systematic review evaluating studies that assessed CTP in patients with aneurysmalSAH for determining delayed cerebral ischemia. Studies using any of the following definitions of delayed cerebral ischemia were included in the systematic review: 1) new onset of clinical deterioration, 2) cerebral infarction identified on follow-up CT or MR imaging, and 3) functional disability. A random-effects meta-analysis was performed assessing the strength of association between a positive CTP result and delayed cerebral ischemia. RESULTS: The systematic review identified 218 studies that met our screening criteria, of which 6 cohort studies met the inclusion criteria. These studies encompassed a total of 345 patients, with 155 (45%) of 345 patients classified as having delayed cerebral ischemia and 190 (55%) of 345 patients as not having delayed cerebral ischemia. Admission disease severity was comparable across all groups. Four cohort studies reported CTP test characteristics amenable to the meta-analysis. The weighted averages and ranges of the pooled sensitivity and specificity of CTP in the determination of delayed cerebral ischemia were 0.84 (0.7-0.95) and 0.77 (0.66-0.82), respectively. The pooled odds ratio of 23.14 (95% CI, 5.87-91.19) indicates that patients with aneurysmalSAH with positive CTP test results were approximately 23 times more likely to experience delayed cerebral ischemia compared with patients with negative CTP test results. CONCLUSIONS: Perfusion deficits on CTP are a significant finding in determining delayed cerebral ischemia in aneurysmalSAH. This may be helpful in identifying patients with delayed cerebral ischemia before development of infarction and neurologic deficits.
Authors: Ellen G Hoeffner; Ian Case; Rajan Jain; Sachin K Gujar; Gaurang V Shah; John P Deveikis; Ruth C Carlos; B Gregory Thompson; Mark R Harrigan; Suresh K Mukherji Journal: Radiology Date: 2004-04-29 Impact factor: 11.105
Authors: Irene van der Schaaf; Marieke J Wermer; Yolanda van der Graaf; Birgitta K Velthuis; Clemens I B van de Kraats; Gabriel J E Rinkel Journal: Stroke Date: 2005-12-22 Impact factor: 7.914
Authors: J Claassen; G L Bernardini; K Kreiter; J Bates; Y E Du; D Copeland; E S Connolly; S A Mayer Journal: Stroke Date: 2001-09 Impact factor: 7.914
Authors: P C Sanelli; N Anumula; C E Johnson; J P Comunale; A J Tsiouris; H Riina; A Z Segal; P E Stieg; R D Zimmerman; A I Mushlin Journal: AJNR Am J Neuroradiol Date: 2012-08-02 Impact factor: 3.825
Authors: Penny Whiting; Anne W S Rutjes; Johannes B Reitsma; Patrick M M Bossuyt; Jos Kleijnen Journal: BMC Med Res Methodol Date: 2003-11-10 Impact factor: 4.615
Authors: Azade Tabaie; Shamim Nemati; Jason W Allen; Charlotte Chung; Flavia Queiroga; Won-Jun Kuk; Adam B Prater Journal: AMIA Annu Symp Proc Date: 2020-03-04
Authors: Ahmed E Othman; Saif Afat; Omid Nikoubashman; Marguerite Müller; Gerrit Alexander Schubert; Georg Bier; Marc A Brockmann; Martin Wiesmann; Carolin Brockmann Journal: Neuroradiology Date: 2016-05-18 Impact factor: 2.804